Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,188 shares at $16.16 ($66K) on 2025-08-19, disclosed to the SEC on 2025-08-21.
Scheduled sale ($66k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.16 | 1,750 | $28K | 42.7% |
| 2 | $15.57 | 2,438 | $38K | 57.3% |
| Total | $15.82 avg | 4,188 | $66K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |